Search PubMed⌕ Search

PubMed · 12605556

Pyrosequencing AB.

Abstract

Pyrosequencing AB develops, manufactures and sells research products that enable life sciences researchers to add utility to the massive amount of genomic information available, with the goal of improving human health. As more genomic information becomes available, research efforts are shifting toward implementing practical applications of this genetic information. Pyrosequencing has developed comprehensive genotyping solutions that provide researchers with rapid and accurate technology for assessing individual genetic variation. Genotypic information is anticipated to play an important role in the emerging field of applied genomics and as a result, significant opportunities may be derived from analyzing genetic variation in individuals and across populations. These data will be key to understanding how genetic differences may be used to determine an individual's predisposition to disease, detect and monitor disease progression, and select the most appropriate therapy and dose and to avoid adverse events. This is pharmacogenomics, an area in which Pyrosequencing technology is being applied and will no doubt continue to enable researchers to ultimately improve human health.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Theresa McNeely. 2003. Pyrosequencing AB.. https://doi.org/10.1517/phgs.4.2.217.22638

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Preventing medication errors with smart infusion technology.

PURPOSE: Processes that pharmacists can use to identify high-risk areas and drugs that require special focus in error-prevention efforts are discussed, with emphasis on the need for i.v. medication error prevention. SUMMARY: Pharmacists can help determine where best to focus medication safety efforts and innovative technology by identifying areas that pose the greatest risk of harm to a patient, such as medications, administration routes, patient care areas, and diagnosis-related groups. Delivery of i.v. medications via infusion devices has traditionally not been a major concern for pharmacists. The introduction of "smart" infusion technology has changed that paradigm by requiring pharmacist involvement in defining minimum and maximum doses for continuous and bolus infusions used within a health care facility. This technology provides a software filter to prevent key-stroke errors in programming infusion devices for delivery of i.v. drugs, as well as a new source of data with which to measure medication errors at the bedside. Implementation of smart infusion technology at Vanderbilt University Medical Center appeared to prevent errors involving heparin. In addition to having an immediate positive impact at the bedside, the technology was relatively easy to implement. CONCLUSION: Smart infusion systems represent an innovative technology that can provide an additional layer of protection at the point of care to help avert i.v. drug errors and prevent patient harm.

Biomedical Technology↗